This content covers the pharmacology of first-line tuberculosis (TB) antitubercular agents — rifampin, isoniazid (INH), pyrazinamide, and ethambutol — within the domain of nursing pharmacology, focusing on mechanism-linked adverse effect profiles and patient teaching priorities. The organizing theoretical principle is that each drug's toxicity profile derives from its pharmacologic mechanism (e.g., INH's interference with vitamin B6/pyridoxine metabolism causing peripheral neuropathy; hepatotoxicity as a shared class effect of antitubercular agents). This body of knowledge sits within infectious disease pharmacology and nursing patient-education practice, relating adverse drug reaction mechanisms to clinical monitoring and teaching frameworks.
This content covers the pharmacology of first-line tuberculosis (TB) antitubercular agents — rifampin, isoniazid (INH), pyrazinamide, and ethambutol — within the domain of nursing pharmacology, focus…